- Home
- HMST vs GNFT Comparison
HMST vs GNFT Comparison
Compare HMST & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- GNFT
- Stock Information
- Founded
- HMST 1921
- GNFT 1999
- Country
- HMST United States
- GNFT France
- Employees
- HMST N/A
- GNFT N/A
- Industry
- HMST Major Banks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HMST Finance
- GNFT Health Care
- Exchange
- HMST Nasdaq
- GNFT Nasdaq
- Market Cap
- HMST 287.6M
- GNFT 296.4M
- IPO Year
- HMST 2012
- GNFT 2019
- Fundamental
- Price
- HMST $11.35
- GNFT $3.82
- Analyst Decision
- HMST Buy
- GNFT Strong Buy
- Analyst Count
- HMST 2
- GNFT 1
- Target Price
- HMST $13.25
- GNFT $13.00
- AVG Volume (30 Days)
- HMST 164.6K
- GNFT 6.8K
- Earning Date
- HMST 01-27-2025
- GNFT 09-19-2024
- Dividend Yield
- HMST N/A
- GNFT N/A
- EPS Growth
- HMST N/A
- GNFT N/A
- EPS
- HMST N/A
- GNFT 0.47
- Revenue
- HMST $169,710,000.00
- GNFT $86,225,222.00
- Revenue This Year
- HMST N/A
- GNFT $155.44
- Revenue Next Year
- HMST $12.08
- GNFT N/A
- P/E Ratio
- HMST N/A
- GNFT $7.73
- Revenue Growth
- HMST N/A
- GNFT 175.45
- 52 Week Low
- HMST $8.09
- GNFT $3.31
- 52 Week High
- HMST $16.10
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- HMST 42.80
- GNFT 26.50
- Support Level
- HMST $11.46
- GNFT $3.73
- Resistance Level
- HMST $11.72
- GNFT $4.06
- Average True Range (ATR)
- HMST 0.37
- GNFT 0.12
- MACD
- HMST 0.05
- GNFT 0.01
- Stochastic Oscillator
- HMST 13.51
- GNFT 12.49
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.